When an owner says a supplement "doesn't work," they might be right.

Not all products are created equal. Not all active ingredients have the same level of evidence. And in some cases, the dog's condition requires something other than a dietary supplement.

However, a failure can also result from a poorly chosen product, incorrect dosage, stopping too soon, or use in a situation where no supplement could reasonably be sufficient.

So the right question is not: "do supplements work or not?"

The real question is: why did the trial not yield results?

Reason 1: the timeframe was not respected

This is one of the most frequent causes.

Many owners stop the trial after 2, 3, or 4 weeks, whereas interesting clinical benchmarks are often around 8 to 12 weeks.

In this case, we can't really speak of failure. We are mostly talking about a test stopped too early.

Studies on some joint nutraceuticals generally evaluate dogs over several weeks, sometimes several months, precisely because the expected improvement is not immediate.

Reason 2: the chosen active ingredient was not necessarily the right one

Not all ingredients have the same level of evidence.

A dog that doesn't respond to glucosamine or chondroitin is not necessarily a dog "resistant to supplements."

It may simply have received a category of active ingredients whose results are weak or disappointing in the available data.

The meta-analysis by Barbeau-Grégoire et al. published in 2022 notably concludes a very marked non-effect of the glucosamine/chondroitin combination on pain in osteoarthritic dogs and cats.

Reason 3: the product did not always contain what it claimed

The actual quality of the product matters greatly.

A supplement may display a nice composition on the label, but be underdosed, poorly formulated, unstable, or unreliable.

In this case, the absence of effect does not necessarily prove that the active ingredient is of no interest. It may simply show that the product used was not serious enough.

This is particularly important for joint supplements, where the quality of raw materials, actual dosages, stability, and traceability can vary greatly from one product to another.

Reason 4: the dose was insufficient

Even a good active ingredient can be disappointing if given at too low a dose.

The dose must be consistent with the dog's weight, the actual concentration of the product, the form used, and doses similar to those evaluated in studies.

Many owners give the supplement diligently, every day, but at a dose that cannot realistically be expected to have an effect.

In this case, the problem is not necessarily with the active ingredient. It may stem from the dosage.

Reason 5: the osteoarthritis was too advanced

In very advanced osteoarthritis, with significant mechanical pain, joint destruction, muscle loss, or long-standing changes, a supplement alone cannot work miracles.

It's not necessarily that the product "doesn't work."

It is sometimes that expectations were too high relative to the stage of the disease.

Recent approaches to canine osteoarthritis emphasize multimodal management: weight management, appropriate activity, pain control, environment, veterinary follow-up, rehabilitation if necessary, and sometimes complementary supplements.

Reason 6: the evaluation was too subjective

When you don't film, don't write anything down, and don't always observe the same situations, you often judge "by impression."

However, the evolution can be subtle.

A dog might get up a little easier, hesitate less before climbing a step, recover faster after an outing, or become stiff less often after rest.

These are real changes, but easy to miss if they are not always observed under the same conditions.

Some owners only realize the benefit when they stop the product, when the dog becomes stiffer again.

Reason 7: the real limiting factor was not addressed

A supplement cannot compensate for everything else.

An overweight dog living on a slippery floor, climbing stairs every day, lacking recovery, or suffering from uncontrolled pain will not be transformed by a supplement, even a well-chosen one.

If weight, environment, activity, recovery, or pain are not managed, the supplement is working under unfavorable conditions.

In this context, it can help a little, but it cannot carry the entire strategy alone.

The right conclusion when facing a failure

Before concluding that a supplement "doesn't work," a few simple questions need to be asked:

• was the trial period sufficient?
• was the chosen active ingredient relevant?
• was the product reliable?
• was the dose consistent with the dog's weight?
• was the osteoarthritis still at a stage where nutritional support could be beneficial?
• were weight, environment, activity, and pain managed?
• was the evolution observed objectively enough?

If several answers are no, the verdict of ineffectiveness is often too hasty.

This does not mean that one should persist with just any supplement.

It means that a trial must be structured: good product, right dog, correct dosage, sufficient timeframe, and realistic expectations.

________________________________________________________________

Sources 

1. Barbeau-Grégoire M. et al. (2022). A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. Not all nutraceuticals are equal; glucosamine/chondroitin showed a marked non-effect, while other categories are more robust.
2. Mehler S.J. et al. (2016). Actual delay of omega-3s and the need for sufficient time before concluding.
3. Hielm-Björkman A. et al. (GLM). Gradual improvement and the benefit of evaluation over several weeks.
4. Pye C. et al. (2024) / multimodal consensus: efficacy also depends on disease stage, weight, environment, and overall strategy.
5. ConsumerLab / product quality sources already used in Article 107: issue of actual composition vs. label on some joint supplements.